Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

被引:108
作者
Richmond, JFL
Lu, S
Santoro, JC
Weng, J
Hu, SL
Montefiori, DC
Robinson, HL
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Dept Infect Dis, Worcester, MA USA
[3] Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC USA
关键词
D O I
10.1128/JVI.72.11.9092-9100.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA vaccination is an effective means of eliciting strong antibody responses to a number of viral antigens. However, DNA immunization alone has not generated persistent, high-titer antibody and neutralizing antibody responses to human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env). We have previously reported that DNA-primed anti-Env antibody responses can be augmented by boosting with Env-expressing recombinant vaccinia viruses. We report here that recombinant Env protein provides a more effective boost of DNA-initiated antibody responses. In rabbits primed with Env-expressing plasmids, protein boosting increased titer, persistence, neutralizing activity, and avidity of anti-Env responses. While titers increased rapidly after boosting, avidity and neutralizing activity matured more slowly over a 6-month period following protein boosting. DNA priming and protein immunization with HIV-1 HXB-2 Env elicited neutralizing antibody for T cell line-adapted, but not primary isolate, viruses. The most effective neutralizing antibody responses were observed after priming with plasmids which expressed noninfectious virus-like particles. In contrast to immunizations with HIV-1 Env, DNA immunizations with the influenza virus hemagglutinin glycoprotein did not require a protein boost to achieve high-titer antibody with good avidity and persistence.
引用
收藏
页码:9092 / 9100
页数:9
相关论文
共 66 条
  • [1] Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
    Barnett, SW
    Rajasekar, S
    Legg, H
    Doe, B
    Fuller, DH
    Haynes, JR
    Walker, CM
    Steimer, KS
    [J]. VACCINE, 1997, 15 (08) : 869 - 873
  • [2] An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1
    Binley, JM
    Arshad, H
    Fouts, TR
    Moore, JP
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (12) : 1007 - 1015
  • [3] Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1
    Binley, JM
    Klasse, PJ
    Cao, YZ
    Jones, I
    Markowitz, M
    Ho, DD
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 2799 - 2809
  • [4] Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
    Boyer, JD
    Ugen, KE
    Wang, B
    Agadjanyan, M
    Gilbert, L
    Bagarazzi, ML
    Chattergoon, M
    Frost, P
    Javadian, A
    Williams, WV
    Refaeli, Y
    Ciccarelli, RB
    McCallus, D
    Coney, L
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (05) : 526 - 532
  • [5] Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein
    Boyle, CM
    Morin, M
    Webster, RG
    Robinson, HL
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 9074 - 9078
  • [6] ANTIGENIC IMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE QUATERNARY STRUCTURE - OLIGOMER-SPECIFIC AND OLIGOMER-SENSITIVE MONOCLONAL-ANTIBODIES
    BRODER, CC
    EARL, PL
    LONG, D
    ABEDON, ST
    MOSS, B
    DOMS, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) : 11699 - 11703
  • [7] CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26
  • [8] CROSS-PROTECTIVE IMMUNE-RESPONSES INDUCED IN RHESUS MACAQUES BY IMMUNIZATION WITH ATTENUATED MACROPHAGE-TROPIC SIMIAN IMMUNODEFICIENCY VIRUS
    CLEMENTS, JE
    MONTELARO, RC
    ZINK, MC
    AMEDEE, AM
    MILLER, S
    TRICHEL, AM
    JAGERSKI, B
    HAUER, D
    MARTIN, LN
    BOHM, RP
    MURPHEYCORB, M
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (05) : 2737 - 2744
  • [9] Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity
    Cole, KS
    Rowles, JL
    Jagerski, BA
    MurpheyCorb, M
    Unangst, T
    Clements, JE
    Robinson, J
    Wyand, MS
    Desrosiers, RC
    Montelaro, RC
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (07) : 5069 - 5079
  • [10] HUMAN STUDIES IN THE DEVELOPMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS VACCINES
    DOLIN, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) : 1175 - 1183